Home LiteratureArticle Details
PMID: 3619418 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.

Antimicrobial agents and chemotherapy ·Vol. 31 ·No. 6 ·1987-06-00 ·Pages 860-4

Drusano GL, Weir M, Forrest A, Plaisance K, Emm T, Standiford HC

Abstract

We examined the pharmacokinetic behavior of 200 mg of ciprofloxacin administered intravenously to 32 volunteers whose renal function as measured by creatinine clearance ranged from 0 to 8.99 liters/h per 1.73 m2. Serum clearances (mean +/- standard deviation) were 26.8 +/- 5.7 and 15.4 +/- 4.3 liters/h per 1.73 m2 in normal and anephric volunteers, respectively. The half-life (mean +/- standard deviation) increased from 4.3 +/- 0.8 h in normal volunteers to 8.6 +/- 3.3 h in anephric volunteers. There was good correlation between normalized creatinine clearance and both normalized serum and renal clearance. The regression equation for serum clearance (CLS) versus creatinine clearance (CLCR) was CLS = 1.97 X CLCR + 13.23, where r = 0.697; for renal clearance versus creatinine clearance, the equation was CLR = 2.26 X CLCR, where r = 0.845. On the basis of these data, we recommend a maximum 50% reduction in dose when ciprofloxacin is instituted at a renal function of 1.2 to 1.8 liters/h per 1.73 m2 (20 to 30 ml/min per 1.73 m2). Because of the observed variation in ciprofloxacin half-life in our anephric volunteers, we also recommend that a schedule of administration every 12 h be maintained, even for patients without urine output.

MeSH Terms
Adult Ciprofloxacin/administration & dosage,metabolism Creatinine/blood Female Half-Life Humans Injections, Intravenous Kidney Diseases/metabolism Kidney Function Tests Kinetics Male Middle Aged
Chemicals
Ciprofloxacin Creatinine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Drusano G L
Weir M
Forrest A
Plaisance K
Emm T
Standiford H C
References (6)
6 references, click to expand
  1. A program package for simulation and parameter estimation in pharmacokinetic systems.
    Comput Programs Biomed. 1979 Mar;9(2):115-34 PMID: 761456
  2. In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
    Antimicrob Agents Chemother. 1984 Mar;25(3):331-5 PMID: 6721464
  3. Absolute oral bioavailability of ciprofloxacin.
    Antimicrob Agents Chemother. 1986 Sep;30(3):444-6 PMID: 3777908
  4. Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis.
    Antimicrob Agents Chemother. 1986 Jul;30(1):152-6 PMID: 2944477
  5. Dose ranging study and constant infusion evaluation of ciprofloxacin.
    Antimicrob Agents Chemother. 1986 Sep;30(3):440-3 PMID: 3777907
  6. The pharmacokinetics of ciprofloxacin in patients with impaired renal function.
    J Antimicrob Chemother. 1985 Jul;16(1):87-93 PMID: 2931415
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1987-06-00
Pages
860-4
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC284200
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]